Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma

Tumor Biology

Volumn 36, Issue 5, 2015, Pages 3355-3359

  Ma, Kang Xiao ^b   Wang, Hong Jie ^a   Li, Xiao Rong ^a   Li, Tao ^a   Su, Gang ^a   Yang, Pan ^a   Wu, Jian Wen ^a  

^a GUANGZHOU RED CROSS HOSPITAL   (China)

^b Ninth people's Hospital of Xi'an   (China)

Author keywords

Glioma; Long noncoding RNA; MALAT1; Prognosis

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN;

ADULT; ARTICLE; BRAIN TISSUE; CANCER PROGNOSIS; CANCER SURVIVAL; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPEN READING FRAME; OVERALL SURVIVAL; PATHOGENESIS; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR VOLUME; AGED; BRAIN TUMOR; GENETICS; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RNA, LONG NONCODING;

EID: 84929956213     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2969-7     Document Type: Article

References (30)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.
4. Dellaretti M, Reyns N, Touzet G, Dubois F, Gusmao S, Pereira JL, et al. Diffuse brainstem glioma: prognostic factors. J Neurosurg. 2012;117:810–4.
5. Johnson DR, Galanis E. Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep. 2013;15:56–63.
6. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74.
7. Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45:604–11.
8. Sun Y, Wang Z, Zhou D. Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas. Med Hypotheses. 2013;81:319–21.
9. Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci. 2012;13:528–41.
10. Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, et al.: Lncrna pro fi le of glioblastoma reveals the potential role of lncrnas in contributing to glioblastoma pathogenesis. International journal of oncology 2012;40:2004–12
11. Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis. 2012;48:1–8.
12. Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK, Ho AS, et al. A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol Dis. 2013;58:123–31.
13. Zhang JX, Han L, Bao ZS, Wang YY, Chen LY, Yan W, et al. Hotair, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro-Oncology. 2013;15:1595–603.
14. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, et al. A pituitary-derived meg3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003;88:5119–26.
15. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA malat1 regulates alternative splicing by modulating sr splicing factor phosphorylation. Mol Cell. 2010;39:925–38.
16. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. Malat-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22:8031–41.
17. Schmidt LH, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D, et al. The long noncoding malat-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol: Off Pub Int Assoc Study Lung Cancer. 2011;6:1984–92.
18. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatol (Baltimore). 2006;44:1012–24.
19. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene. 2007;26:851–8.
20. Han Y, Liu Y, Nie L, Gui Y, Cai Z. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology. 2013;81:209 e1–7.
21. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated malat-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol BioSyst. 2012;8:2289–94.
22. Fellenberg J, Bernd L, Delling G, Witte D, Zahlten-Hinguranage A. Prognostic significance of drug-regulated genes in high-grade osteosarcoma. Mod Pathol: Off J United States Can Acad Pathol. 2007;20:1085–94.
23. Lai NS, Dong QS, Ding H, Miao ZL, Lin YC. Microrna-210 overexpression predicts poorer prognosis in glioma patients. J Clin Neurosci: Off J Neurosurg Soc Australas. 2014;21:755–60.
24. Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA meg3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868–74.
25. Guffanti A, Iacono M, Pelucchi P, Kim N, Solda G, Croft LJ, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics. 2009;10:163.
26. Praz V, Jagannathan V, Bucher P. Cleanex: a database of heterogeneous gene expression data based on a consistent gene nomenclature. Nucleic Acids Res. 2004;32:D542–7.
27. Yamada K, Kano J, Tsunoda H, Yoshikawa H, Okubo C, Ishiyama T, et al. Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci. 2006;97:106–12.
28. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9:e1003368.
29. Guo F, Li Y, Liu Y, Wang J, Li Y, Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin. 2010;42:224–9.
30. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol (London, England). 2012;29:1810–6.